Overview Fundamentals API Earnings EOD API Sample Code Pricing

Crinetics Pharmaceuticals Inc (CRNX NASDAQ) stock market data APIs

$54.69 -0.29(-0.5%) as of July 16, 2024
Price chart is built with Anychart

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Crinetics Pharmaceuticals Inc Financial Data Overview

54.98
54.69
-
55.77
54.49
15.76-55.77
4 269 M
78 860 K
1 974 K
-0.93
0.683
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CRNX',
Type: 'Common Stock',
Name: 'Crinetics Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00BC59224',
ISIN: NULL,
CUSIP: NULL,
CIK: '1658247',
EmployerIdNumber: '26-3744114',
FiscalYearEnd: 'December',
IPODate: '2018-07-18',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Crinetics Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 974 K
  • EBITDA -246 870 000
  • Earnings Per Share -3.77
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Crinetics Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.81

Get Crinetics Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com